0.860
0.01 (0.87%)
| Previous Close | 0.853 |
| Open | 0.860 |
| Volume | 86,423 |
| Avg. Volume (3M) | 116,745 |
| Market Cap | 40,281,508 |
| Price / Earnings (Forward) | 11.70 |
| Price / Sales | 5.37 |
| Price / Book | 0.860 |
| 52 Weeks Range | |
| Earnings Date | 17 Aug 2026 |
| Operating Margin (TTM) | -749.51% |
| Diluted EPS (TTM) | -0.770 |
| Quarterly Revenue Growth (YOY) | 1.20% |
| Total Debt/Equity (MRQ) | 8.19% |
| Current Ratio (MRQ) | 4.36 |
| Operating Cash Flow (TTM) | -25.60 M |
| Levered Free Cash Flow (TTM) | -13.62 M |
| Return on Assets (TTM) | -58.16% |
| Return on Equity (TTM) | -113.95% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | InspireMD Inc. | Mixed | Mixed |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 1.5 |
| Technical Oscillators | 2.0 |
| Average | 1.33 |
|
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Value |
| % Held by Insiders | 30.14% |
| % Held by Institutions | 42.29% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Affiance Financial, Llc | 30 Jun 2026 | 250,370 |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |